CDC Logo Skip Top Nav
 CDC Home PageSearch the CDCHealth Topics A though Z
Skip
Division of Tuberculosis Elimination
About DTBE Upcoming Events Site Map CDC en Espanol Contact Us
 
Skip the Contents menu

Contents

Skip the Resources menu

Resources



U.S. Department of Health and Human Services
 
 

Guide to the Application of Genotyping to Tuberculosis Prevention and Control

Return to Genotyping Main Menu

Combining Genotyping and Epidemiologic
Data to Improve Our Understanding of
Tuberculosis Transmission

Comparing Genotyping Results from Three or More TB Patients

In the previous discussion, we focused on possible transmission between just two TB patients. When a genotyping cluster grows to include three or more patients, additional information becomes available that can shed light on how the patients’ cases might be related.

As additional TB patients are diagnosed and found to belong to a previously identified genotyping cluster, more information about possible epidemiologic links becomes available. The greater the number of leads an investigator has to follow-up, the greater the chance of identifying a shared link among patients in a cluster.

Data on additional patients is also helpful in identifying endemic strains that are often found in the absence of evidence of recent transmission. When a TB program first initiates a genotyping program, it will be difficult to identify endemic strains until data from many patients are gathered and analyzed. After several years, a TB program will be able to identify M. tuberculosis strains that are commonly detected in their area but are rarely associated with patients who share known epidemiologic links.

 

Last Reviewed: 05/18/2008
Content Source: Division of Tuberculosis Elimination
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

 

 
Back to Top of Page


If you would like to order any of the DTBE publications please visit the online order form.

You will need Adobe Acrobat™ Reader v5.0 or higher to read pages that are in PDF format.  Download the Adobe Acrobat™ Reader.

If you have difficulty accessing any material on the DTBE Web site because of a disability, please contact us in writing or via telephone and we will work with you to make the information available.

Division of Tuberculosis Elimination
Attn: Content Manager, DTBE Web site
Centers for Disease Control and Prevention
1600 Clifton Rd., NE Mailstop E-10
Atlanta, GA 30333
CDC-INFO at (1-800) 232-4636
TTY: 1 (888) 232-6348
E-mail: cdcinfo@cdc.gov


Skip Bottom Nav Home | Site Map | Contact Us
Accessibility | Privacy Policy Notice | FOIA | USA.gov
CDC Home | Search | Health Topics A-Z

Centers for Disease Control & Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination
Please send comments/suggestions/requests to: CDCINFO@cdc.gov